Facile preparation of poly(N-isopropylacrylamide)/graphene oxide nanocomposites for chemo-photothermal therapy.

Carbon-based nanomaterials, such as carbon nanotubes, fullerenes, nanodiamonds, and graphene, have been investigated for various biomedical applications, including biological imaging, photothermal therapy, drug/gene delivery, cancer therapy, biosensors, and electrochemical sensors. Graphene oxide (GO) has unique physicochemical properties and can be used to restore conductivity through oxidation. In this study, we developed poly(N-isopropylacrylamide) (PNIPAM)-based nanogel systems containing GO for controlled in vitro drug delivery. The photothermal effects of the PNIPAM/GO- and PNIPAMAAM/GO-based nanogel systems were enhanced. The release of DOX from the PNIPAM/GO-based nanogel was achieved using the photothermal effect of near-infrared irradiation. Using a Cell Counting Kit-8 assay, the cytotoxicity of all conditions demonstrated that the PNIPAM composite-based nanogels were biocompatible with no significance.

Test by NMR of the phase coherence of electromagnetically induced transparency.

Electromagnetically induced transparency is an effect observed in atomic systems, originating from quantum interference, in which electromagnetic transitions to and from a certain quantum state become suppressed. This dark state is also characterized by a quantum phase, relative to other states, which theoretically should stop evolving, but remain phase coherent, during transparency. We test this theoretical prediction using techniques developed for liquid-state nuclear magnetic resonance quantum computation, applied to a spin-7/2 nuclear spin system. A sequence of quantum operations is applied to create the dark state, and during transparency its phase evolution is measured relative to a reference state using Ramsey interferometry. Experimental measurements of the fringe visibility are in excellent agreement with theoretical expectations, taking into account measured decoherence rates.